Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10.
N Engl J Med. 2019.
PMID: 31075187
Clinical Trial.
Elevated D-dimer as an immediate response to alemtuzumab treatment.
Libertinova J, Meluzinova E, Nema E, Rockova P, Elisak M, Petrzalka M, Mojzisova H, Hammer J, Tomek A, Marusic P.
Libertinova J, et al. Among authors: rockova p.
Mult Scler. 2021 Jan;27(1):151-154. doi: 10.1177/1352458520904277. Epub 2020 Feb 20.
Mult Scler. 2021.
PMID: 32077356
Item in Clipboard
IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
Petržalka M, Meluzínová E, Libertínová J, Mojžišová H, Hanzalová J, Ročková P, Elišák M, Kmetonyová S, Šanda J, Sobek O, Marusič P.
Petržalka M, et al. Among authors: rockova p.
PLoS One. 2022 Jun 27;17(6):e0270607. doi: 10.1371/journal.pone.0270607. eCollection 2022.
PLoS One. 2022.
PMID: 35759479
Free PMC article.
Item in Clipboard
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D, Menkyova I, Drahota J, Mazouchova A, Adamkova J, Ampapa R, Grunermelova M, Peterka M, Recmanova E, Rockova P, Rous M, Stetkarova I, Valis M, Vachova M, Woznicova I, Horakova D.
Stastna D, et al. Among authors: rockova p.
Mult Scler Relat Disord. 2021 Sep;54:103104. doi: 10.1016/j.msard.2021.103104. Epub 2021 Jun 24.
Mult Scler Relat Disord. 2021.
PMID: 34216998
Free PMC article.
Item in Clipboard
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021.
Stastna D, Drahota J, Lauer M, Mazouchova A, Menkyova I, Adamkova J, Ampapa R, Dufek M, Grunermelova M, Hradilek P, Kubala Havrdova E, Mares J, Martinkova A, Pavelek Z, Peterka M, Recmanova E, Rockova P, Stetkarova I, Stourac P, Vachova M, Horakova D.
Stastna D, et al. Among authors: rockova p.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Apr 28. doi: 10.5507/bp.2023.015. Online ahead of print.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023.
PMID: 37114703
Item in Clipboard
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS.
Horakova D, Rockova P, Jircikova J, Dolezal T, Vachova M, Hradilek P, Valis M, Sucha J, Martinkova A, Ampapa R, Grunermelova M, Stetkarova I, Stourac P, Mares J, Dufek M, Kmetova E, Adamkova J, Hrnciarova T.
Horakova D, et al. Among authors: rockova p.
Mult Scler Relat Disord. 2019 Oct;35:196-202. doi: 10.1016/j.msard.2019.08.003. Epub 2019 Aug 3.
Mult Scler Relat Disord. 2019.
PMID: 31400559
Item in Clipboard
Cite
Cite